Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01841463 |
| Title | Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation |
| Recruitment | Suspended |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Piramal Enterprises Limited |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCSF Medical Center at Mount Zion | South San Francisco | California | 94115 | United States | Details | |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | United States | Details | |
| Georgetown-Lombardi Comprehensive Cancer Ctr | Washington | District of Columbia | 20057 | United States | Details | |
| The University of Texas, MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |